Ingersoll Rand(US:IR)2025-10-31 12:00Financial Performance - Q3 2025 orders increased by 8%, while revenue increased by 5%[13] - Adjusted EBITDA increased by 2%, but the adjusted EBITDA margin decreased by 70 bps[13] - Adjusted EPS increased by 2% year-over-year[13] - Free cash flow was approximately flat year-over-year[17] - Total available liquidity was $3.8 billion, including $1.2 billion in cash and cash equivalents and $2.6 billion available from the revolving credit facility[17] Segment Performance - Industrial Technologies & Services revenue increased by 5%, with organic growth declining by 2.1%[21] - Precision & Science Technologies revenue increased by 5.3%, with organic growth of 1.7%[28] - Precision & Science Technologies adjusted EBITDA margin increased by 80 bps year over year[28] M&A Activity - Year-to-date, the company closed 14 transactions[11] - Expected annualized inorganic revenue acquired is approximately $250 million[11] - The company expects to acquire 400-500 bps of annualized inorganic revenue in 2025[11] Full-Year 2025 Guidance - Total revenue is expected to grow by 4-6%[31] - Organic revenue is expected to decline by 2% to 0%[31] - Adjusted EBITDA is projected to be $2.06 billion - $2.09 billion, representing a 2-4% year-over-year increase[31] - Adjusted EPS is expected to be $3.25 - $3.31, representing a (1%) - +1% year-over-year change[31]